Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
---|
12/18/1991 | EP0108128B1 (met-1,des-cys1,des-tyr2,des-cys3) human gamma interferon and a dna sequence encoding it |
12/16/1991 | WO1991019805A1 A novel vector to produce biologically important peptides |
12/16/1991 | CA2084678A1 Vector to produce biologically important peptides |
12/04/1991 | EP0459536A1 Chromogenic acridinone enzyme substrates |
12/04/1991 | CN1056713A Anti-oncostatin m monoclonal antibodies |
11/21/1991 | EP0456766A1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE |
11/21/1991 | EP0456662A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants |
11/13/1991 | EP0236385B1 A superoxide dismutase |
11/11/1991 | WO1991017250A1 Method for the recombinant production of hiridius and hirudin-like polypeptides |
11/11/1991 | CA2063575A1 Method for the recombinant production of hirudins and hirudin-like polypeptides |
10/31/1991 | WO1991016349A1 Expression of recombinant hemoglobin in yeast |
10/31/1991 | WO1991009118A3 Activatable fibrinolytic and anti-thrombotic proteins |
10/31/1991 | CA2080589A1 Expression of recombinant hemoglobin in yeast |
10/30/1991 | EP0453458A1 Process for the introduction of exogenous dna in somatic and germ animal cells. |
10/17/1991 | WO1991015588A1 Recombinant yeasts containing the dna sequences coding for xylose reductase- and xylitol dehydrogenase enzymes |
10/17/1991 | WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
10/09/1991 | CN1014242B Prepn. of thiadiazole compounds |
09/24/1991 | CA2038580A1 Biological oxidation of sulfide ore |
09/18/1991 | CN1054616A Dna fragment encoding polypeptide having nitrile hydratase activity, transformant containing gene and process for production amides using transformant |
09/18/1991 | CN1054613A Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses |
09/11/1991 | EP0445646A2 DNA fragment encoding a polypeptide having nitrile hydratase activity, a transformant containing the DNA fragment and a process for the production of amides using the transformant |
09/11/1991 | EP0188479B1 Lymphokine production and purification |
08/21/1991 | CN1013586B Process for hydridoma cell line of monoclonal antibody of recoverying leukocytes in human peripheral blood |
08/13/1991 | WO1991012020A1 Novel vaccine and method therefor |
08/07/1991 | EP0440304A1 Fungal resistant plants, process for obtaining fungal resistant plants and recombinant polynucleotides for use therein |
08/06/1991 | US5037806 Biologically active method using somatotropins |
07/31/1991 | CA2035134A1 Fungal resistant plants, process for obtaining fungal resistant plants and recombinant polynucleotides for use therein |
07/19/1991 | CA2034385A1 Vector to produce biologically important peptides |
07/13/1991 | WO1991010741A1 Generation of xenogeneic antibodies |
07/13/1991 | CA2050918A1 Generation of xenogeneic antibodies |
07/11/1991 | WO1991009967A1 Humanised antibodies |
07/11/1991 | WO1991009966A1 Cd4 specific recombinant antibody |
07/11/1991 | WO1991000343A3 Mutant enzyme having reduced stability under industrial application conditions |
07/03/1991 | EP0434747A1 Viral vaccines |
07/03/1991 | EP0434721A1 Viral nucleotide sequences |
06/27/1991 | WO1991008761A1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
06/23/1991 | WO1991009955A1 Endogenous gene expression modification with regulatory element |
06/22/1991 | WO1991009968A1 Cd3 specific recombinant antibody |
06/20/1991 | CA2032675A1 Platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
06/13/1991 | WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
06/08/1991 | WO1991009125A1 Proteins and nucleic acids |
06/08/1991 | WO1991009118A2 Activatable fibrinolytic and anti-thrombotic proteins |
06/08/1991 | CA2069105A1 Proteins and nucleic acids |
06/05/1991 | EP0429600A1 Saf polypeptide, gene, promoter and use for expression in streptomyces |
06/05/1991 | CN1051937A Stem cell factor |
05/18/1991 | WO1991007490A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2135744A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2068728A1 Protein complexes having factor viii:c activity and production thereof |
05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
05/15/1991 | CN1051302A Biologically active proteins and method for their prodn. |
05/14/1991 | US5015573 DNA vectors and their use in recombinant DNA technology |
05/08/1991 | CN1051199A Modified biological material |
05/07/1991 | US5013661 Lipopolysaccharide-specific acyloxyacyl hydrolase |
05/02/1991 | WO1991005855A1 Modified biological material |
05/02/1991 | EP0424990A1 The manufacture and expression of large structural genes |
05/02/1991 | EP0424484A1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection. |
05/02/1991 | CA2067235A1 Modified biological material |
05/01/1991 | CN1051058A Cloning and expression of microbial phytase |
04/24/1991 | EP0423980A1 Stem cell factor |
04/24/1991 | EP0423845A1 A synthetic gene encoding gamma-interferon |
04/18/1991 | WO1991005053A1 Cloning and expression of microbial phytase |
04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
04/17/1991 | EP0422697A1 A consensus leukocyte interferon and a gene encoding it |
04/17/1991 | EP0422339A1 Tumor necrosis factor (TNF) inhibitor and method for obtaining the same |
04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
04/16/1991 | CA1283066C Monoclonal antibody specific to neutrophils |
04/03/1991 | EP0420358A1 Cloning and expression of microbial phytase |
03/27/1991 | CN1050220A Mutant microbial alpha-amylases with increased thermal, acid and/or alkaline stability |
03/21/1991 | WO1991003252A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
03/13/1991 | CN1049866A Efficient production of mutant proteases |
03/12/1991 | CA1281287C Protection of equines against streptococcus equi |
02/27/1991 | EP0414297A1 Efficient production of mutant proteases |
02/21/1991 | WO1991002069A1 Plants with modified flowers |
02/21/1991 | WO1991000353A3 MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY |
02/20/1991 | EP0413383A1 Mutants of human interleukin-3 |
02/13/1991 | EP0412911A1 Plants with modified flowers |
02/06/1991 | EP0231209B1 Virus vaccine |
01/30/1991 | EP0410498A2 Mutant microbial alpha-amylases with increased thermal, acid and/or alkaline stability |
01/30/1991 | EP0410147A1 Modified VP1/P2A regions of rhinovirus systems |
01/24/1991 | WO1990014426A3 Saf polypeptide, gene, promoter and use for expression in streptomyces |
01/23/1991 | EP0409299A2 Mutant enzyme having reduced stability under industrial application conditions |
01/19/1991 | CA2021369A1 Tumor necrosis factor (tnf) inhibitor and method for obtaining the same |
01/17/1991 | DE4020211A1 New rhinoviral DNA with mutation(s) in protease 2A region - and corresponding oligo:nucleotide(s) and oligopeptide(s), useful in test systems and as therapeutic competitive inhibitors |
01/10/1991 | WO1991000353A2 MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY |
01/10/1991 | WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system |
01/10/1991 | WO1991000347A1 Method of producing proteins with fviii activity and/or fviii derivatives |
01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
12/30/1990 | WO1991000343A2 Mutant enzyme having reduced stability under industrial application conditions |
12/30/1990 | CA2032518A1 Mutant enzyme having reduced stability under industrial application conditions |
12/27/1990 | EP0403900A2 Electroacoustical loudspeaker device |
12/25/1990 | US4980163 Lysostaphin and lanthionine containing bacteriocin |
12/25/1990 | CA2019661A1 Modified vp1/p2a region of the rhinovirus system |
12/05/1990 | EP0400545A1 Derivative of tissue plasminogen activator |
12/05/1990 | CN1047531A Hog cholera virus vaccine and diagnostic |
11/28/1990 | CN1047340A Therapeutic agent |
11/20/1990 | WO1990014426A2 Saf polypeptide, gene, promoter and use for expression in streptomyces |
10/30/1990 | CA1275625C Virus vaccine |
10/29/1990 | WO1990013561A1 Therapeutic agent |
10/24/1990 | EP0393502A1 Soluble interferon-gamma receptors and methods for their production |
10/19/1990 | CA2014752A1 Soluble interferon-gamma receptors and methods for their production |